{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:58:46Z","timestamp":1758124726576,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.cellimm.2013.07.020","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T21:24:44Z","timestamp":1375910684000},"page":"172-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Significant modulation of macrophages associated cytokines TNF-\u03b1, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells"],"prefix":"10.1016","volume":"284","author":[{"given":"Pankaj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirshendu","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annpurna","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhnrita","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samarendra Nath","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapna","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2013.07.020_b0005","first-page":"508","article-title":"Grading glioma tumors using OWL-DL and NCI Thesaurus","volume":"39","author":"Marquet","year":"2007","journal-title":"AMIA Annu. Symp. Proc."},{"key":"10.1016\/j.cellimm.2013.07.020_b0010","first-page":"613215","article-title":"The WHO classification of tumors of the nervous system","author":"Kleihues","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0015","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0959-8049(03)00603-8","article-title":"Cause of death and long-term survival in patients with neuro-epithelial brain tumors: a population based study","volume":"39","author":"Johannesen","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cellimm.2013.07.020_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.imlet.2010.03.003","article-title":"Microglial action in glioma: a boon turns bane","volume":"131","author":"Ghosh","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellimm.2013.07.020_b0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.272.5258.50","article-title":"The instructive role of innate immunity in the acquired immune response","volume":"272","author":"Fearon","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2013.07.020_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/abbs\/gmr120","article-title":"Comparative evaluation of T11TS structure and its deglycosilated derivatives nullifies the importance of glycan moieties in immunotherapeutic efficacy","volume":"44","author":"Chatterjee","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.cellimm.2013.07.020_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CAD.0b013e32833276e8","article-title":"Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1\/Kip1 and concurrent downregulation of cyclin D (1 and 3)","volume":"21","author":"Acharya","year":"2010","journal-title":"Ant. Can. Drugs"},{"key":"10.1016\/j.cellimm.2013.07.020_b0040","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/intimm\/dxn109","article-title":"Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation","volume":"20","author":"Bhattacharjee","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/B:GLYC.0000043287.98081.15","article-title":"Documentation of immune profile of microglia through cells surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS\/SLFA-3","volume":"20","author":"Begum","year":"2004","journal-title":"J. Glycoconj."},{"key":"10.1016\/j.cellimm.2013.07.020_b0050","first-page":"10","article-title":"Sheep form of leucocyte function antigen-3 (TIITS) exerts immunostimulatory and anti tumor activity against experimental brain tumor: a new approach to biological response modifier therapy","volume":"21","author":"Sarkar","year":"2002","journal-title":"J. Exp. Clin. Can. Res."},{"key":"10.1016\/j.cellimm.2013.07.020_b0055","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.4049\/jimmunol.126.6.2117","article-title":"A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rossette formation","volume":"126","author":"Howard","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cellimm.2012.05.006","article-title":"Immunomodulatory role of TIITS in respect to cytotoxic lymphocytes in four grades of human glioma","volume":"276","author":"Kumar","year":"2012","journal-title":"Cell. Immunol."},{"year":"1993","series-title":"Histological Typing of Tumours of the Central Nervous System. International Histological Classification of Tumours","author":"Kleihues","key":"10.1016\/j.cellimm.2013.07.020_b0065"},{"key":"10.1016\/j.cellimm.2013.07.020_b0070","first-page":"798","article-title":"A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters","volume":"7","author":"McKeever","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0075","unstructured":"Y. Schedule (amended version, 2005), Indian Drug and Cosmetic Law, 1940, <website.cdsco.nic.in>."},{"key":"10.1016\/j.cellimm.2013.07.020_b0080","unstructured":"Good Clinical Practice, Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health and Family Welfare, Govt. of India, New Delhi, Drug Controller General, India."},{"key":"10.1016\/j.cellimm.2013.07.020_b0085","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2013.07.020_b0090","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1349-7006.2007.00633.x","article-title":"Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis","volume":"98","author":"Kimura","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellimm.2013.07.020_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","article-title":"The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages","volume":"66","author":"Allavena","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","article-title":"The origin and function of tumor-associated macrophages","volume":"13","author":"Mantovani","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cellimm.2013.07.020_b0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjc.6690158","article-title":"Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast","volume":"79","author":"Leek","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellimm.2013.07.020_b0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G","article-title":"Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas","volume":"192","author":"Lewis","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cellimm.2013.07.020_b0120","first-page":"2898","article-title":"Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen","volume":"60","author":"Adams","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2013.07.020_b0125","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/jlb.54.6.613","article-title":"Involvement of inflammatory mediators in macrophage antitumor activity","volume":"54","author":"Bonta","year":"1993","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0130","first-page":"203","article-title":"The role of macrophages in tumor development","volume":"27","author":"Bij","year":"2005","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clinbiochem.2006.09.009","article-title":"TGF-\u03b21, TNF-\u03b1 and cytochrome c in human astrocytic tumors: a short-term follow up and correlation with survival","volume":"40","author":"Mabrouk","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cellimm.2013.07.020_b0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1054\/bjoc.1999.0945","article-title":"CD3 directed bispecific antibodies induce increased Lymphocyte-endothelial cell interactions in vitro","volume":"82","author":"Molema","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellimm.2013.07.020_b0145","first-page":"2905","article-title":"Immunotherapy with T11TS\/S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status","volume":"25","author":"Mukharjee","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cellimm.2013.07.020_b0150","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/1078-0432.CCR-04-2223","article-title":"Cell death independent of caspases: a review","volume":"11","author":"Broker","year":"2005","journal-title":"Clin. Cancer"},{"key":"10.1016\/j.cellimm.2013.07.020_b0155","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signaling and modulation","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2013.07.020_b0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2013.07.020_b0165","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1158\/0008-5472.CAN-05-2097","article-title":"The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death","volume":"66","author":"Manero","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2013.07.020_b0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cellimm.2013.07.020_b0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.21221","article-title":"The prognostic relevance of molecular alterations in glioblastomas for patients age <50years","volume":"104","author":"Korshunov","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cellimm.2013.07.020_b0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbamcr.2003.10.010","article-title":"Shooting at survivors: Bcl-2 family members as drug targets for cancer","volume":"1644","author":"Juin","year":"2004","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.cellimm.2013.07.020_b0185","first-page":"1693","article-title":"BCL-2 gene family and the regulation of programmed cell death","volume":"59","author":"Korsmeyer","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2013.07.020_b0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0952-7915(98)80221-5","article-title":"Cancer: tuning in on death programs","volume":"10","author":"Korsmeyer","year":"1998","journal-title":"Curr. Opin. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874913001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874913001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:52:22Z","timestamp":1757803942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874913001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0008874913001354"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2013.07.020","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant modulation of macrophages associated cytokines TNF-\u03b1, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2013.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}